1Anthonisen NR, Connett JE, Klley Jp, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodllator on the rate of decline of FEV: The Lung Health Study. JAMA. 1994;272:1497-1505.
2Burns DM. Primary Preverntion, Smoking, Smoking Cessation: Implications For future Trends in Lung Cancer Prevention: Proceedings of the International Conference on Prevertion and Early Diagnosis of Lung Cancer, Varese Italy, 9-10.December,1998. 1998;164-1713.
3Shaw GL. Chemoprevention of Secondary Primary Lung Cancer: Proceedings of the international Conference on Prevention and Early Diagnosis of Lung Cancer, Varese, Italy, 9-10 December, 1998. 1998;221-226.
4Koike T, Terashima M, Takizawa T, et al. The influence of tung cancer mass screening on surgical results. Lung Cancer. 1999;24:75-80.
5Saito Y, Nogamoto N, Ota S, et al. Results of surgical treatment for roentgenographiocally occult bronchogenic squamous cell carclnoma J Thorac Cardiovasc Surg. 1992;104:401-407.
6The Health Beneflts of Smoking Cessation:A Report of Washington, DC: US Dept of Health and Human Services; 1900.Publication CDC 90-8416
7Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonaly disease: National Heart, Lung, and Blood Institute workshop Summary. JAMA. 1997;277:246-253.
8Feguson GT, Enright PL, Buist AS, Hlggins MW. Office spirometry for lung health assessmentin adults:a consensus statement from the National Lung Health Education Program. Chest. 2000;117:1146-1161.
9Moon MA. Imaging reveals indolent cancer. Internal Medicine News. 2000;33:1,5.
10Petty TL. It's time to Dick the low-hanging fruit Chest. 2000;117:1-2.
